{"organizations": [], "uuid": "fdd860fc195fe74eaec15aee542f69e76bf22ddc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "", "site_section": "http://feeds.reuters.com/reuters/technologysectorNews\r", "section_title": "Reuters: Technology", "url": "http://www.reuters.com/article/2015/10/13/idUSFWN12D00G20151013?feedType=RSS&feedName=technologySector", "country": "US", "title": "BRIEF-Median Technologies says awarded new projects and contracts worth 4.09 mln euros", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "BRIEF-Median Technologies says awarded new projects and contracts worth 4.09 mln euros", "spam_score": 0.0, "site_type": "news", "published": "2015-10-13T19:23:00.000+03:00", "replies_count": 0, "uuid": "fdd860fc195fe74eaec15aee542f69e76bf22ddc"}, "author": "", "url": "http://www.reuters.com/article/2015/10/13/idUSFWN12D00G20151013?feedType=RSS&feedName=technologySector", "ord_in_thread": 0, "title": "BRIEF-Median Technologies says awarded new projects and contracts worth 4.09 mln euros", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "BRIEF-Median Technologies says awarded new projects and contracts worth 4.09 mln euros \nOct 13 Median Technologies SA : \n* Says awarded new projects and new contracts for image interpretation and management in clinical trials totaling 4.09 million euros ($4.65 million) \n* Awarded projects include a phase III study (gastric cancer) for a total of 1.75 million euros \n* a phase III study (rare and aggressive cutaneous cancer) for a total of 1.51 million euros \n* Awarded projects include a phase II study (melanoma) for a total of 335,000 euros \n* Contracts awarded include a phase I/II study (liver cancer) for a total of 394,000 euros \n* Contracts awarded include a phase II study (primary central nervous system lymphoma) for a total of 103,000 euros \nSource text for Eikon: Further company coverage: ($1 = 0.8788 euros) (Gdynia Newsroom) Trending On Reuters", "external_links": [], "published": "2015-10-13T19:23:00.000+03:00", "crawled": "2015-10-13T23:23:38.613+03:00", "highlightTitle": ""}